Skip to main content
. 2025 Mar 11;100(Suppl 4):88–115. doi: 10.1002/ajh.27655

FIGURE 4.

FIGURE 4

Evidence‐based hierarchical classification of TP53‐mutated (TP53 mut) myeloid neoplasms (MN). AML—acute myeloid leukemia; CK—complex karyotype; EB—excess blasts; LB—low (< 5% blasts); MDS—myelodysplastic syndrome; OS—overall survival (calculated from diagnosis); VAF—variant allele frequency. Adapted from Shah et al. (Blood Adv, in print).